A biotech start-up has taken space at The Oxford Trust’s Wood Centre for Innovation in Headington, Oxford.
Bioarchitech, a firm developing immunotherapy for the treatment of common cancer, has taken 870 sq ft in the building.
The company has moved from the BioEscalator at the University of Oxford’s Old Road Campus, to enable expansion and widen its research programme.
Bioarchitech is one of nine early-stage companies based at the Wood Centre for Innovation, which includes DJS Antibodies, Samsara Therapeutics, Helio Display Materials, Jack Fertility, Lumai, Spintex, RedShiftBio, and PicturaBio.
Bioarchitech co-founder Kevin Maskell said: “Cancer patients are in desperate need of the promising immunotherapies that we have in development. The Oxford Trust and the supportive community they have built at the Wood Centre for Innovation is the ideal home for our team to focus on the research needed to make these treatments a reality.”
Steve Burgess, chief executive officer for the trust, said: “We warmly welcome Bioarchitech to our innovation community at the Wood Centre for Innovation. With R&D lab and office space in a beautiful woodland setting right in the heart of the Headington Science Cluster, we now have nine pioneering companies based in our centre, all pushing the boundaries of research and development with breakthroughs in biotech and advancements in deeptech, driving positive change.”
© Thames Tap (powered by ukpropertyforums.com).
Sign up to receive our weekly free journal, The Forum here.
